NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|82617606|ref|NP_001032393|]
View 

arylamine N-acetyltransferase 1 [Rattus norvegicus]

Protein Classification

arylamine N-acetyltransferase( domain architecture ID 10466656)

arylamine N-acetyltransferase catalyzes the transfer of an acetyl group from acetyl coenzyme A (CoA) to the nitrogen or oxygen atom of a wide variety of aromatic amines (arylamines) and hydrazines

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
20-280 8.65e-119

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


:

Pssm-ID: 395644  Cd Length: 240  Bit Score: 340.41  E-value: 8.65e-119
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606    20 DLATLTEVLQHQMRAVPFENLSMHCGEAMCLGLEATFDHIVRKKRGGWCLQVNHLLYWALTKMGFETTMLGGYVYITPVN 99
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   100 KYSSEMVHLLVQVTISDRNYIVDSAYGSSYqMWEPLELTSGKDQPQVPAIFRLTEEN-GTWYLDQIRREQDVPnqefvns 178
Cdd:pfam00797  81 AYSTPQTHLLLLVTIDGETYLVDVGFGGST-LWAPLELISGKDQPTPHGIFRLVEEGgGTWYLEKDGRDGWVP------- 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   179 dllekskyrkIYSFTLEPRTIEDFEYVNTYLQTSPASVFVSTSFCSLQTSEGVCCLIGSTLTSRrfsYKDNVdLVEFKSL 258
Cdd:pfam00797 153 ----------LYSFTLEPRQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPDGRLTLTGRTLTLR---YKDGA-LVEIRLL 218
                         250       260
                  ....*....|....*....|..
gi 82617606   259 TEEEIEDVLKTTFGISLEKKFV 280
Cdd:pfam00797 219 TDEEVEDVLKERFGIELDAKLV 240
 
Name Accession Description Interval E-value
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
20-280 8.65e-119

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


Pssm-ID: 395644  Cd Length: 240  Bit Score: 340.41  E-value: 8.65e-119
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606    20 DLATLTEVLQHQMRAVPFENLSMHCGEAMCLGLEATFDHIVRKKRGGWCLQVNHLLYWALTKMGFETTMLGGYVYITPVN 99
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   100 KYSSEMVHLLVQVTISDRNYIVDSAYGSSYqMWEPLELTSGKDQPQVPAIFRLTEEN-GTWYLDQIRREQDVPnqefvns 178
Cdd:pfam00797  81 AYSTPQTHLLLLVTIDGETYLVDVGFGGST-LWAPLELISGKDQPTPHGIFRLVEEGgGTWYLEKDGRDGWVP------- 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   179 dllekskyrkIYSFTLEPRTIEDFEYVNTYLQTSPASVFVSTSFCSLQTSEGVCCLIGSTLTSRrfsYKDNVdLVEFKSL 258
Cdd:pfam00797 153 ----------LYSFTLEPRQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPDGRLTLTGRTLTLR---YKDGA-LVEIRLL 218
                         250       260
                  ....*....|....*....|..
gi 82617606   259 TEEEIEDVLKTTFGISLEKKFV 280
Cdd:pfam00797 219 TDEEVEDVLKERFGIELDAKLV 240
NhoA COG2162
Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];
1-276 1.32e-67

Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 441765  Cd Length: 256  Bit Score: 210.89  E-value: 1.32e-67
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   1 MDIEAYFERIGYKNSVnKLDLATLTEVLQHQMRAVPFENLSMHCGEAMCLGLEATFDHIVRKKRGGWCLQVNHLLYWALT 80
Cdd:COG2162   3 FDLDAYLARIGYSGPP-APTLETLRALHRAHVRAIPFENLDVLLGRPISLDPDALFDKLVRRRRGGYCYELNGLFAALLE 81
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606  81 KMGFETTMLGGYVYITPVNKYSSEMVHLLVQVTISDRNYIVDSAYGsSYQMWEPLELTSGKDQPQVPAIFRLTEE-NGTW 159
Cdd:COG2162  82 ALGFDVTLLAARVRWGGPGGPGPPRTHMALLVTLDGERWLVDVGFG-GGTPLEPLPLEDGTEQDQPGGTYRLVRSdDGEW 160
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606 160 YLdQIRREQDvpnqefvnsdllekskYRKIYSFTLEPRTIEDFEYVNTYLQTSPASVFVSTSFCSLQTSEGVCCLIGSTL 239
Cdd:COG2162 161 VL-QRRVDGG----------------WRPLYRFDLEPQELADFEVANWYTSTHPDSPFVGNLLVARATPDGRVTLRGRRL 223
                       250       260       270
                ....*....|....*....|....*....|....*..
gi 82617606 240 TSRRfsykDNVDlVEFKSLTEEEIEDVLKTTFGISLE 276
Cdd:COG2162 224 TRRR----GGGE-EERTLLSAEELAAVLRERFGLDLD 255
PRK15047 PRK15047
N-hydroxyarylamine O-acetyltransferase; Provisional
3-284 1.12e-12

N-hydroxyarylamine O-acetyltransferase; Provisional


Pssm-ID: 185007  Cd Length: 281  Bit Score: 66.79  E-value: 1.12e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606    3 IEAYFERIGYKNSVnKLDLATLTEVLQHQMRAVPFENLSMHCGEAMCLGLEATFDHIVRKKRGGWCLQVNHLLYWALTKM 82
Cdd:PRK15047   5 LNAYFARINWSGAA-AVNIDTLRALHLKHNCTIPFENLDVLLPREIQLDDQSLEEKLVIARRGGYCFEQNGLFERVLREL 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   83 GFET-TMLGGYVYITPVNKysSEMVHLLVQVTISDRNYIVDSAYGSSyQMWEPLELTSGKDQPQVPAIFRLTEENGTWYL 161
Cdd:PRK15047  84 GFNVrSLLGRVVLSNPPAL--PPRTHRLLLVELEGEKWIADVGFGGQ-TLTAPIRLVADIVQTTPHGEYRLLQEGDDWVL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606  162 dQIRREQdvpnqefvnsdlleksKYRKIYSFTLEPRTIEDFEYVNTYLQTSPASVFVSTSFCSLQTSEGvccliGS-TLT 240
Cdd:PRK15047 161 -QFNHHQ----------------HWQSMYRFDLCEQQQSDYVMGNFWSAHWPQSHFRHHLLMCRHLPDG-----GKlTLT 218
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*
gi 82617606  241 SRRFSYKDNVDLVEFKSLTE-EEIEDVLKTTFGISLEKkfvPKHG 284
Cdd:PRK15047 219 NFHFTHYENGHAVEQRNLPDvASLYAVMQEQFGLGVDD---AKHG 260
 
Name Accession Description Interval E-value
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
20-280 8.65e-119

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


Pssm-ID: 395644  Cd Length: 240  Bit Score: 340.41  E-value: 8.65e-119
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606    20 DLATLTEVLQHQMRAVPFENLSMHCGEAMCLGLEATFDHIVRKKRGGWCLQVNHLLYWALTKMGFETTMLGGYVYITPVN 99
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   100 KYSSEMVHLLVQVTISDRNYIVDSAYGSSYqMWEPLELTSGKDQPQVPAIFRLTEEN-GTWYLDQIRREQDVPnqefvns 178
Cdd:pfam00797  81 AYSTPQTHLLLLVTIDGETYLVDVGFGGST-LWAPLELISGKDQPTPHGIFRLVEEGgGTWYLEKDGRDGWVP------- 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   179 dllekskyrkIYSFTLEPRTIEDFEYVNTYLQTSPASVFVSTSFCSLQTSEGVCCLIGSTLTSRrfsYKDNVdLVEFKSL 258
Cdd:pfam00797 153 ----------LYSFTLEPRQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPDGRLTLTGRTLTLR---YKDGA-LVEIRLL 218
                         250       260
                  ....*....|....*....|..
gi 82617606   259 TEEEIEDVLKTTFGISLEKKFV 280
Cdd:pfam00797 219 TDEEVEDVLKERFGIELDAKLV 240
NhoA COG2162
Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];
1-276 1.32e-67

Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 441765  Cd Length: 256  Bit Score: 210.89  E-value: 1.32e-67
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   1 MDIEAYFERIGYKNSVnKLDLATLTEVLQHQMRAVPFENLSMHCGEAMCLGLEATFDHIVRKKRGGWCLQVNHLLYWALT 80
Cdd:COG2162   3 FDLDAYLARIGYSGPP-APTLETLRALHRAHVRAIPFENLDVLLGRPISLDPDALFDKLVRRRRGGYCYELNGLFAALLE 81
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606  81 KMGFETTMLGGYVYITPVNKYSSEMVHLLVQVTISDRNYIVDSAYGsSYQMWEPLELTSGKDQPQVPAIFRLTEE-NGTW 159
Cdd:COG2162  82 ALGFDVTLLAARVRWGGPGGPGPPRTHMALLVTLDGERWLVDVGFG-GGTPLEPLPLEDGTEQDQPGGTYRLVRSdDGEW 160
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606 160 YLdQIRREQDvpnqefvnsdllekskYRKIYSFTLEPRTIEDFEYVNTYLQTSPASVFVSTSFCSLQTSEGVCCLIGSTL 239
Cdd:COG2162 161 VL-QRRVDGG----------------WRPLYRFDLEPQELADFEVANWYTSTHPDSPFVGNLLVARATPDGRVTLRGRRL 223
                       250       260       270
                ....*....|....*....|....*....|....*..
gi 82617606 240 TSRRfsykDNVDlVEFKSLTEEEIEDVLKTTFGISLE 276
Cdd:COG2162 224 TRRR----GGGE-EERTLLSAEELAAVLRERFGLDLD 255
PRK15047 PRK15047
N-hydroxyarylamine O-acetyltransferase; Provisional
3-284 1.12e-12

N-hydroxyarylamine O-acetyltransferase; Provisional


Pssm-ID: 185007  Cd Length: 281  Bit Score: 66.79  E-value: 1.12e-12
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606    3 IEAYFERIGYKNSVnKLDLATLTEVLQHQMRAVPFENLSMHCGEAMCLGLEATFDHIVRKKRGGWCLQVNHLLYWALTKM 82
Cdd:PRK15047   5 LNAYFARINWSGAA-AVNIDTLRALHLKHNCTIPFENLDVLLPREIQLDDQSLEEKLVIARRGGYCFEQNGLFERVLREL 83
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606   83 GFET-TMLGGYVYITPVNKysSEMVHLLVQVTISDRNYIVDSAYGSSyQMWEPLELTSGKDQPQVPAIFRLTEENGTWYL 161
Cdd:PRK15047  84 GFNVrSLLGRVVLSNPPAL--PPRTHRLLLVELEGEKWIADVGFGGQ-TLTAPIRLVADIVQTTPHGEYRLLQEGDDWVL 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82617606  162 dQIRREQdvpnqefvnsdlleksKYRKIYSFTLEPRTIEDFEYVNTYLQTSPASVFVSTSFCSLQTSEGvccliGS-TLT 240
Cdd:PRK15047 161 -QFNHHQ----------------HWQSMYRFDLCEQQQSDYVMGNFWSAHWPQSHFRHHLLMCRHLPDG-----GKlTLT 218
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*
gi 82617606  241 SRRFSYKDNVDLVEFKSLTE-EEIEDVLKTTFGISLEKkfvPKHG 284
Cdd:PRK15047 219 NFHFTHYENGHAVEQRNLPDvASLYAVMQEQFGLGVDD---AKHG 260
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH